查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495544

依替唑仑市场：依形式、应用分类 - 全球预测 2024-2030

Etizolam Market by Form (Powders, Solutions, Tablet), Applications (Anxiety, Insomnia, Panic Disorders) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年依替唑仑市场规模为6,815万美元，2024年达7,133万美元，预计2030年将达9,507万美元，复合年增长率为4.86%。

依替唑仑是噻吩并二氮杂卓类药物中的一种化合物，其结构和功能与苯二氮平类药物相似。它主要用于镇静和抗焦虑作用。它的作用是增强大脑中一种名为 GABA 的神经传导物质的作用，这种神经传导物质在调节神经系统活动方面发挥作用，并对身体有镇静作用。依替唑仑可有效治疗焦虑和失眠，但它也存在潜在的风险和副作用，包括依赖性。越来越多的人患有焦虑和睡眠障碍，这增加了对依替唑仑等有效治疗方法的需求。然而，有关依替唑仑核准的严格规定给製造商带来了重大挑战。此外，最近的技术进步使得医学领域的研究变得更加有效和有针对性。对于依替唑仑市场，增加研发投资可能会导致开发出更安全、更有效、副作用更少的製剂。这可能会扩大依替唑仑的治疗用途，并将其定位为需要苯二氮平样作用的治疗的首选。

主要市场统计
基准年[2023] 6815万美元
预测年份 [2024] 7133万美元
预测年份 [2030] 9507万美元
复合年增长率（%） 4.86%

区域洞察

在美洲，依替唑仑未经美国食品药物管理局(FDA)核准。由于担心滥用和成瘾，它在美国的几个州是非法的。同时，加拿大认识到滥用依替唑仑的可能性，并致力于对进口和分销进行严格的监管和监控。美洲市场受到监管政策的强烈影响，进而对消费行为产生重大影响。在受监管的领域，人们明显倾向于购买合法且同样有效的替代品。美国是医药创新中心，目前正在进行多项关于更安全的依替唑仑替代品的研究，重点是降低依赖风险。专利通常围绕着配方改进或相关物质的新治疗用途。依替唑仑的法律地位在欧盟国家之间有所不同，但与亚洲相比，其使用普遍受到控制，对处方和分销有严格的规定。欧盟国家广泛关注心理健康，为研究更安全、更有效的依替唑仑替代品铺平了道路。此外，中东有严格的毒品法，减少了此类化合物的供应。相较之下，非洲的监管控制各不相同，很大程度上受到国家政策的影响，进而影响可用性和消费行为。此外，亚洲、中国、日本和印度对于依替唑仑市场极为重要，这主要是因为它们人口众多且监管状况各异。在日本，依替唑仑经常用于医疗机构，但受到严格控制。与日本不同，中国和印度对依替唑仑的监管较不严格，因此相对较容易取得，并且具有不同的使用和购买模式。最近在印度和中国的投资重点是扩大药品生产能力，包括生产各种抗焦虑药物，如依替唑仑。

FPNV定位矩阵

FPNV 定位矩阵对于评估 Etizolam 市场供应商定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对依替唑仑市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在依替唑仑市场的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于焦虑症和失眠的增加，需求增加
      • 逐步改革医疗保健政策以促进获得药品
    • 抑制因素
      • 与产品召回相关的担忧
    • 机会
      • 增加治疗应用研发 (R&D) 的投资
      • 与其他製药公司和学术机构共同开发
    • 任务
      • 仿冒品氾滥
  • 市场区隔分析
    • 形式：粉状依替唑仑在锭剂和液体溶液製剂中的用途
    • 用途：依替唑仑常用于短期治疗焦虑和恐慌发作。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 依替唑仑市场：依形式

  • 粉末
  • 解决方案
  • 药片

第七章 依替唑仑市场：依应用分类

  • 焦虑
  • 失眠
  • 恐慌症

第八章 美洲依替唑仑市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太地区依替唑仑市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的依替唑仑市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Hikma Pharmaceuticals 推出Diazepam注射液 USP 扩大美国产品组合
  • 战略分析和建议

第十二章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-5D693B46C001

[189 Pages Report] The Etizolam Market size was estimated at USD 68.15 million in 2023 and expected to reach USD 71.33 million in 2024, at a CAGR 4.86% to reach USD 95.07 million by 2030.

Etizolam is a chemical compound that belongs to the class of drugs known as thienodiazepines, which are similar in structure and function to benzodiazepines. It is used primarily for its sedative and anxiolytic properties, meaning it helps to reduce anxiety and promote sleep. It works by enhancing the effect of a neurotransmitter in the brain called GABA, which plays a role in regulating nervous system activity and has a calming effect on the body. While Etizolam can be effective for treating anxiety and insomnia, it is also associated with potential risks and side effects, including dependency. The increasing number of individuals suffering from anxiety and sleep disorders boosts the demand for effective therapeutic agents such as Etizolam, which is known for its efficacy in treating such conditions. However, the strict regulations related to the approval of Etizolam are a significant challenge for manufacturers. Moreover, recent technological advancements have allowed for more effective and targeted research in the field of medicine. For the etizolam market, increased R&D investment can lead to developing safer, more effective formulations with reduced side effects. This can broaden the therapeutic applications of Etizolam, potentially positioning it as a preferred option in treatments where benzodiazepine-like effects are desired.

KEY MARKET STATISTICS
Base Year [2023] USD 68.15 million
Estimated Year [2024] USD 71.33 million
Forecast Year [2030] USD 95.07 million
CAGR (%) 4.86%

Regional Insights

In the Americas, Etizolam is not approved by the U.S. Food and Drug Administration (FDA). It is illegal in several states within the U.S. due to concerns over abuse and addiction. Meanwhile, Canada recognizes the potential misuse of etizolam, which influences strict regulations and a focus on monitoring imports and distribution. The market in the Americas is strongly influenced by regulatory policies, which, in turn, affect consumer behavior significantly. In territories where it is restricted, there's a noticeable pivot towards purchasing legal and similarly effective alternatives. The United States, being a hub for pharmaceutical innovation, has several ongoing studies on safer alternatives to etizolam, focusing on reducing dependency risks. Patents usually revolve around formulation enhancements and new therapeutic applications for related substances. The legal status of etizolam varies by country within the EU; however, its use is generally more controlled compared to Asia, with strict regulations regarding prescription and distribution. EU countries focus extensively on mental health, which paves the way for research into safer and more effective alternatives to etizolam. In addition, the Middle East has stringent narcotic drug laws which reduce the availability of such compounds. In contrast, Africa has varying regulatory controls, influenced largely by individual country policies, which affect availability and consumer behavior. Moreover, Asia, China, Japan, and India are pivotal in the market of etizolam, primarily due to their large population bases and varying regulatory landscapes. In Japan, etizolam is notably used in medical settings but is strictly controlled. Unlike Japan, China and India have less stringent controls over etizolam, making it relatively more accessible and leading to different patterns of use and purchase. Recent investments in India and China focus on expanding pharmaceutical manufacturing capabilities, including producing various anxiolytics like etizolam.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Etizolam Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increased demand due to the rising prevalence of anxiety disorders and insomnia
      • Progressive reforms in healthcare policies facilitating drug accessibility
    • Market Restraints
      • Concerns associated with the product recall
    • Market Opportunities
      • Increased investment in research and development (R&D) for therapeutic applications
      • Collaborative development with other pharmaceutical companies and academic institutions
    • Market Challenges
      • Prevalence of counterfeit products
  • Market Segmentation Analysis
    • Form: Utilization of powdered Etizolam in the formulation of tablets and liquid solutions
    • Applications: Extensive usage of Etizolam for short-term treatment of anxiety and panic attacks
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Etizolam Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Etizolam Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Hikma Pharmaceuticals Expands US Portfolio with Introduction of Diazepam Injection USP

Hikma Pharmaceuticals has announced the launch of Diazepam Injection USP, a generic drug version. This product is intended for the treatment of conditions such as anxiety, muscle spasms, and certain types of seizures, offering a critical medical solution in both hospital and outpatient settings. As part of its ongoing commitment to addressing medicine shortages and critical care needs, Hikma emphasizes that this addition aligns with its mission to provide accessible, high-quality treatments that cater to urgent and essential therapeutic demands. [Published On: 2023-05-02]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Etizolam Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Etizolam Market, highlighting leading vendors and their innovative profiles. These include Arinna Lifescience Pvt Ltd., Centurion Laboratories, Chempro Pharma Private Limited, Consern Pharma Private Limited, Dr Reddy's Laboratories Ltd., Eridanus Healthcare, Inc., Hikma Pharmaceuticals PLC, Icon Life Sciences, Intas Pharmaceuticals Ltd., Jabs Biotech Pvt. Ltd., Macleods Pharmaceuticals Pvt Ltd., Mankind Pharma Ltd., Merck KGaA, Micro Labs Ltd., Neuracle Lifesciences Private Limited, NIHON GENERIC Co., Ltd., Santa Cruz Biotechnology, Inc., Sun Pharmaceutical Industries Ltd., Talent India, Tas Med India Pvt Ltd., and TCI Chemicals.

Market Segmentation & Coverage

This research report categorizes the Etizolam Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Form
    • Powders
    • Solutions
    • Tablet
  • Applications
    • Anxiety
    • Insomnia
    • Panic Disorders
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased demand due to the rising prevalence of anxiety disorders and insomnia
      • 5.1.1.2. Progressive reforms in healthcare policies facilitating drug accessibility
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with the product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased investment in research and development (R&D) for therapeutic applications
      • 5.1.3.2. Collaborative development with other pharmaceutical companies and academic institutions
    • 5.1.4. Challenges
      • 5.1.4.1. Prevalence of counterfeit products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Form: Utilization of powdered Etizolam in the formulation of tablets and liquid solutions
    • 5.2.2. Applications: Extensive usage of Etizolam for short-term treatment of anxiety and panic attacks
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Etizolam Market, by Form

  • 6.1. Introduction
  • 6.2. Powders
  • 6.3. Solutions
  • 6.4. Tablet

7. Etizolam Market, by Applications

  • 7.1. Introduction
  • 7.2. Anxiety
  • 7.3. Insomnia
  • 7.4. Panic Disorders

8. Americas Etizolam Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Etizolam Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Etizolam Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Hikma Pharmaceuticals Expands US Portfolio with Introduction of Diazepam Injection USP
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ETIZOLAM MARKET RESEARCH PROCESS
  • FIGURE 2. ETIZOLAM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ETIZOLAM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ETIZOLAM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ETIZOLAM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ETIZOLAM MARKET DYNAMICS
  • FIGURE 7. GLOBAL ETIZOLAM MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ETIZOLAM MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ETIZOLAM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ETIZOLAM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ETIZOLAM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. ETIZOLAM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ETIZOLAM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ETIZOLAM MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ETIZOLAM MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ETIZOLAM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ETIZOLAM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ETIZOLAM MARKET SIZE, BY POWDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ETIZOLAM MARKET SIZE, BY POWDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ETIZOLAM MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ETIZOLAM MARKET SIZE, BY SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ETIZOLAM MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ETIZOLAM MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ETIZOLAM MARKET SIZE, BY ANXIETY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ETIZOLAM MARKET SIZE, BY ANXIETY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ETIZOLAM MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ETIZOLAM MARKET SIZE, BY INSOMNIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ETIZOLAM MARKET SIZE, BY PANIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ETIZOLAM MARKET SIZE, BY PANIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. AMERICAS ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 24. AMERICAS ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS ETIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS ETIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 30. ARGENTINA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 32. ARGENTINA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 33. BRAZIL ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 34. BRAZIL ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 35. BRAZIL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 36. BRAZIL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 37. CANADA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 38. CANADA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 39. CANADA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 40. CANADA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 41. MEXICO ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 42. MEXICO ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 43. MEXICO ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 44. MEXICO ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 46. UNITED STATES ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 48. UNITED STATES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ETIZOLAM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 50. UNITED STATES ETIZOLAM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 58. AUSTRALIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 60. AUSTRALIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 61. CHINA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 62. CHINA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 63. CHINA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 64. CHINA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 65. INDIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 66. INDIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 67. INDIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 68. INDIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 69. INDONESIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 70. INDONESIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 71. INDONESIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 72. INDONESIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 73. JAPAN ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 74. JAPAN ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 75. JAPAN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 76. JAPAN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 78. MALAYSIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 80. MALAYSIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 82. PHILIPPINES ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 84. PHILIPPINES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 86. SINGAPORE ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 88. SINGAPORE ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 90. SOUTH KOREA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 92. SOUTH KOREA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 93. TAIWAN ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 94. TAIWAN ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 95. TAIWAN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 96. TAIWAN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 97. THAILAND ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 98. THAILAND ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 99. THAILAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 100. THAILAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 101. VIETNAM ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 102. VIETNAM ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 103. VIETNAM ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 104. VIETNAM ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 111. DENMARK ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 112. DENMARK ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 113. DENMARK ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 114. DENMARK ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 115. EGYPT ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 116. EGYPT ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 117. EGYPT ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 118. EGYPT ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 119. FINLAND ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 120. FINLAND ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 121. FINLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 122. FINLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 123. FRANCE ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 124. FRANCE ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 125. FRANCE ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 126. FRANCE ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 127. GERMANY ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 128. GERMANY ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 129. GERMANY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 130. GERMANY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 131. ISRAEL ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 132. ISRAEL ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 133. ISRAEL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 134. ISRAEL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 135. ITALY ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 136. ITALY ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 137. ITALY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 138. ITALY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 140. NETHERLANDS ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 142. NETHERLANDS ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 143. NIGERIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 144. NIGERIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 145. NIGERIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 146. NIGERIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 147. NORWAY ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 148. NORWAY ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 149. NORWAY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 150. NORWAY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 151. POLAND ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 152. POLAND ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 153. POLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 154. POLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 155. QATAR ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 156. QATAR ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 157. QATAR ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 158. QATAR ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 159. RUSSIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 160. RUSSIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 161. RUSSIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 162. RUSSIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 166. SAUDI ARABIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH AFRICA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 171. SPAIN ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 172. SPAIN ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 173. SPAIN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 174. SPAIN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 175. SWEDEN ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 176. SWEDEN ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 177. SWEDEN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 178. SWEDEN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 180. SWITZERLAND ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 182. SWITZERLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 183. TURKEY ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 184. TURKEY ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 185. TURKEY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 186. TURKEY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 194. UNITED KINGDOM ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 195. ETIZOLAM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. ETIZOLAM MARKET, FPNV POSITIONING MATRIX, 2023